These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31673229)

  • 41. Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists.
    Nilles KM; Caldwell SH; Flamm SL
    Hepatol Commun; 2019 Nov; 3(11):1423-1434. PubMed ID: 31701067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease.
    Cheloff AZ; Al-Samkari H
    J Blood Med; 2019; 10():313-321. PubMed ID: 31565009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures.
    Ding Z; Wu H; Zeng Y; Kuang M; Yang W; Meng Z; Chen Y; Hao C; Zou S; Sun H; Liu C; Lin K; Shi G; Wang X; Fu X; Chen R; Chen Y; Liang R; Kano T; Pan H; Yang S; Fan J; Zhou J
    Hepatol Int; 2023 Feb; 17(1):180-189. PubMed ID: 36258065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
    Katsube T; Shimizu R; Fukuhara T; Kano T; Wajima T
    Clin Pharmacokinet; 2019 Nov; 58(11):1469-1482. PubMed ID: 31055790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Thrombopoietin Receptor Agonist Lusutrombopag Is Effective for Patients with Chronic Liver Disease and Impaired Renal Function.
    Takeuchi H; Furuichi Y; Yoshimasu Y; Kasai Y; Abe M; Sugimoto K; Itoi T
    J Nippon Med Sch; 2021 Jan; 87(6):325-333. PubMed ID: 32238734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelets in liver disease, cancer and regeneration.
    Kurokawa T; Ohkohchi N
    World J Gastroenterol; 2017 May; 23(18):3228-3239. PubMed ID: 28566882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease.
    Mladsi D; Barnett C; Aggarwal K; Vredenburg M; Dieterich D; Kim R
    Clinicoecon Outcomes Res; 2020; 12():515-526. PubMed ID: 32982341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Avatrombopag for the management of thrombocytopenia in patients with chronic liver disease.
    Lozano ML
    Rev Esp Enferm Dig; 2021 Feb; 113(2):136-140. PubMed ID: 33233913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics.
    Gebetsberger J; Streif W; Dame C
    Hamostaseologie; 2024 Jun; ():. PubMed ID: 38925157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Avatrombopag maleate for the treatment of periprocedural thrombocytopenia in patients with chronic liver disease.
    Al-Samkari H
    Drugs Today (Barc); 2018 Nov; 54(11):647-655. PubMed ID: 30539164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures.
    Barnett CL; Mladsi D; Vredenburg M; Aggarwal K
    J Med Econ; 2018 Aug; 21(8):827-834. PubMed ID: 29912593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pathophysiology of thrombocytopenia in chronic liver disease.
    Mitchell O; Feldman DM; Diakow M; Sigal SH
    Hepat Med; 2016; 8():39-50. PubMed ID: 27186144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis.
    Loffredo L; Violi F
    Dig Liver Dis; 2019 Jan; 51(1):24-27. PubMed ID: 29958825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently.
    Yassin MA; Al-Rasheed M; Al-Khaboori M; Marashi M; Osman H; Wali Y; Al Kindi S; Alsayegh F; Provan D
    Front Cardiovasc Med; 2023; 10():1260487. PubMed ID: 38162126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies.
    Kuter DJ; Allen LF
    Br J Haematol; 2018 Nov; 183(3):466-478. PubMed ID: 30203841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments.
    Aiello A; Mariano EE; Prada M; Teruzzi C; Martone N; Capri S; Carli G; Siragusa S
    J Mark Access Health Policy; 2023; 11(1):2230663. PubMed ID: 37405228
    [No Abstract]   [Full Text] [Related]  

  • 57. Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
    Flisiak R; Antonov K; Drastich P; Jarcuska P; Maevskaya M; Makara M; Puljiz Ž; Štabuc B; Trifan A
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of three or more treatments with lusutrombopag in patients with cirrhotic thrombocytopenia: A retrospective single-center study.
    Kawaratani H; Tsuji Y; Ishida K; Kaya D; Kubo T; Fujinaga Y; Sawada Y; Sato S; Takaya H; Kaji K; Namisaki T; Moriya K; Akahane T; Yoshiji H
    Hepatol Res; 2020 Sep; 50(9):1101-1105. PubMed ID: 32558192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeated Lusutrombopag Treatment for Thrombocytopenia in Patients with Chronic Liver Disease.
    Sano Y; Morimoto M; Kobayashi S; Ueno M; Fukushima T; Asama H; Kawano K; Nagashima S; Tanaka S; Ohkawa S; Maeda S
    Digestion; 2021; 102(4):654-662. PubMed ID: 32841939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel functions of platelets in the liver.
    Kurokawa T; Zheng YW; Ohkohchi N
    J Gastroenterol Hepatol; 2016 Apr; 31(4):745-51. PubMed ID: 26632220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.